Sorensen to head Siemens Healthcare in U.S., Canada

Source: Siemens Healthcare
Siemens Healthcare has appointed neurologist Gregory Sorensen, MD, as CEO of Siemens Healthcare in the U.S., effective June 1. Sorensen succeeds Randy Hill, who has served as interim CEO. Sorensen also will oversee the Canadian activities of Siemens Healthcare.

Sorensen will be responsible for leading the marketing, sales, service and support functions for Siemens Healthcare in the U.S. and Canada, across the entire healthcare portfolio including medical imaging, therapy, health IT and laboratory diagnostics. He will be based at Siemens Healthcare's U.S. headquarters in Malvern, Pa.

Sorensen is currently serving as professor of radiology and health sciences & technology at Harvard Medical School; is a faculty member of the Harvard-Massachusetts Institute of Technology division of health sciences and technology; and co-director of the A.A. Martinos Center for Biomedical Imaging at Massachusetts General Hospital in Boston.

He is a practicing neuroradiologist whose research has focused on novel oncology agents, such as gene therapy.

Around the web

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.